|
RVMD Revolution Medicines Inc 1628171 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-453,816,000.00 |
| Balance Sheet |
|
Current Assets
|
$1,967,913,000.00 |
|
Assets
|
$2,253,737,000.00 |
|
Current Liabilities
|
$289,599,000.00 |
|
Liabilities
|
$753,820,000.00 |
|
Equity
|
$1,499,917,000.00 |
|
Shares Out
|
200178626.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-354,165,000.00 |
|
Investing Cash Flow
|
$172,615,000.00 |
| Market Analysis |
Market Cap
|
$38,468,326,558.42 |
|
Price
|
$181.89 |
|
BVPS
|
7.49 |
|
PB
|
25.66 |
|
EPS
|
-2.29 |
|
FCF
|
$-355,703,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:13 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:07 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-25 |
-1.86 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
-2.29 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-1.31 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-1.61 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RVMD documents filed with the SEC.
RVMD Filings
Clear
